Finanzen von PetIQ Inc (PETQ)PETQPetIQ Inc

PetIQ Inc (PETQ) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Products, accounting for 88.5% of total sales, equivalent to $291.20M. Another important revenue stream is Services. Understanding this composition is critical for investors evaluating how PETQ navigates market cycles within the Pharmaceuticals industry.

Evaluating the bottom line, PetIQ Inc maintains a gross margin of 26.84%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 8.63%, while the net margin is 4.70%. These profitability ratios, combined with a Return on Equity (ROE) of 5.37%, provide a clear picture of how effectively PETQ converts its operational activities into shareholder value.

In the context of the broader market, PETQ competes directly with industry leaders such as SAGE and EOLS. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, PETQ's gross margin of 26.84% stands against SAGE's 100.00% and EOLS's 66.19%. Such benchmarking helps identify whether PetIQ Inc is trading at a premium or discount relative to its financial performance.